# ADYNXX, INC.: Form D filings

ADYNXX, INC., a pharmaceuticals company in San Francisco, CA, filed 4 Form D notices with the SEC between 2010 and 2017. The latest, on January 19, 2017, reports $16 million sold of a $16 million offering to 3 investors.

Find out what ADYNXX, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20ADYNXX%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=ADYNXX%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fadynxx-inc-1427066)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20ADYNXX%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=ADYNXX%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fadynxx-inc-1427066)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 100 Pine Street, Suite 500, San Francisco, CA, 94111
- Phone: (415) 512-7740
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1427066

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 19, 2017 | New notice | $15,999,999 | $15,999,999 | $0 | 3 | Dec 20, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1427066/000142706617000003/0001427066-17-000003-index.htm) |
| Dec 27, 2010 | New notice | $15,803,857 | $4,803,858 | $10,999,999 | 8 | Dec 9, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1427066/000142706610000004/0001427066-10-000004-index.htm) |
| Dec 8, 2010 | New notice | $39,098 | $39,098 | $0 | 10 | Aug 1, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1427066/000142706610000003/0001427066-10-000003-index.htm) |
| Aug 3, 2010 | New notice | $740,560 | $740,560 | $0 | 8 | Nov 8, 2007 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1427066/000142706610000002/0001427066-10-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Donald Manning | Executive Officer |  |
| Dennis Podlesak | Director |  |
| Stan Abel | Director |  |
| Julien Mamet | Executive Officer, Director |  |
| Scott Harris | Executive Officer |  |
| Eckard Weber | Director |  |
| Rick Orr | Executive Officer, Director |  |
| Heath Lukatch | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Jan 16, 2017](https://specstream.ai/data/form-d/week/2017-01-16) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what ADYNXX, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).